Please login to the form below

Not currently logged in
Email:
Password:

NICE to oversee GP quality indicators

NICE will oversee the annual reviewing of Quality and Outcomes Framework indicators for GPs from April 1.

The National Institute for Health and Clinical Excellence (NICE) will oversee the annual reviewing of Quality and Outcomes Framework (QOF) indicators for GPs from April 1.

This decision follows a 13-week consultation that included clinicians, patient organisations, NHS commissioners and the public.

A key part of NICE's role will involve the creation of an independent Primary Care Quality and Outcomes Framework Indicator Advisory Committee who will be responsible for reviewing existing indicators and recommending new ones. However, the final say on QOF indicators will be negotiated between the British Medical Association (BMA) and NHS employers.

Commenting on the announcement Val Moore, NICE implementation director said: "The purpose of NICE evidence-based guidance is to support professionals in making best use of NHS resources. It is sometimes confusing for professionals when different pieces of national guidance don't recommend the same things."

As part of its new role, NICE will collate information in order to prioritise new indicators based on evidence of clinical and cost-effectiveness. A facility on the NICE website will allow interested parties to submit potential public health and clinical priority topics. The Advisory Committee will consider these topics and their relative priorities.

19th March 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics